Article
[The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer].
Aktuelle Urologie - 1 Dec 2020
Thelen P, Taubert H, Duensing S, Kristiansen G, Merseburger A S, Cronauer M V
Abstract excerpt
A recently discovered mechanism enabling prostate cancer cells to escape the effects of endocrine therapies consists in the synthesis of C-terminally truncated, constitutively active androgen receptor (AR) splice variants (AR-V). Devoid of a functional C-terminal hormone/ligand binding domain, various AR-Vs are insensitive to therapies targeting the androgen/AR signalling axis. Preliminary studies suggest that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
